CXCL10 and bacterial vaginosis: While participant variation was evident, sEcad and IP-10 emerged as promising biomarkers of vaginal microbiome dynamics during a symptomatic BV event and MET treatment due to their levels strongly impacted by microbiome factors and their distinct interaction patterns with DL and BVT species.